UBS Group
PILL icon

UBS Group’s Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL Stock Holding History

UBS Group’s Portfolio PILL Stock Details PILL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.5K Buy
+1,225
New +$14.4K ﹤0.01% 8249
2025
Q4 		– Sell
-3,412
Closed -$27.5K – 11012
2025
Q3 		$27.5K Sell
3,412
-7,871
-70% -$53.4K ﹤0.01% 7952
2025
Q2 		$58.3K Buy
11,283
+10,280
+1,025% +$53.3K ﹤0.01% 7653
2025
Q1 		$7.24K Buy
+1,003
New +$7.51K ﹤0.01% 8843
2024
Q3 		– Sell
-7,533
Closed -$46.9K – 9928
2024
Q2 		$46.9K Buy
7,533
+6,668
+771% +$44.4K ﹤0.01% 6738
2024
Q1 		$7.11K Buy
+865
New +$7.24K ﹤0.01% 7411
2023
Q1 		– Sell
-549
Closed -$4.92K – 10189
2022
Q4 		$4.92K Sell
549
-3,179
-85% -$30.6K ﹤0.01% 9247
2022
Q3 		$33K Buy
3,728
+3,385
+987% +$37.5K ﹤0.01% 6768
2022
Q2 		$4K Buy
+343
New +$3.84K ﹤0.01% 9101

Other funds holding PILL

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
FC
Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group's PILL Position: Q1 2026 in Review

UBS Group opened a new position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) in Q1 2026: 1,225 shares worth $12.5K. The stake represents ﹤0.01% of the portfolio and ranks #8249 among its holdings. This is a return to the name: UBS Group previously reported a position in PILL as recently as Q3 2025.

UBS Group first reported a position in PILL in Q2 2022 and has held it in 9 quarters since. The position peaked at $58.3K in Q2 2025. 5 funds tracked by Wall St. Rank hold PILL as of Q1 2026.

  • UBS Group held 1,225 shares of Direxion Daily Pharmaceutical & Medical Bull 3X ETF worth $12.5K as of Q1 2026.
  • Direxion Daily Pharmaceutical & Medical Bull 3X ETF was a new UBS Group position in Q1 2026.
  • Direxion Daily Pharmaceutical & Medical Bull 3X ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8249 holding.
  • UBS Group first reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in Q2 2022 and has held it in 9 quarters since.
  • UBS Group's Direxion Daily Pharmaceutical & Medical Bull 3X ETF position peaked at $58.3K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Direxion Daily Pharmaceutical & Medical Bull 3X ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.